MG
BMY icon

Marex Group’s Bristol-Myers Squibb BMY Stock Holding History

Marex Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,477
Closed -$332K – 1154
2026
Q1 		$332K Sell
5,477
-1,382
-20% -$80.6K ﹤0.01% 740
2025
Q4 		$370K Buy
+6,859
New +$330K ﹤0.01% 648
2025
Q3 		– Sell
-12,772
Closed -$591K – 866
2025
Q2 		$591K Sell
12,772
-120,684
-90% -$5.92M 0.01% 357
2025
Q1 		$8.14M Sell
133,456
-2,917
-2% -$170K 0.16% 80
2024
Q4 		$7.71M Buy
136,373
+132,327
+3,271% +$7.39M 0.13% 79
2024
Q3 		$209K Sell
4,046
-1,878
-32% -$88.1K ﹤0.01% 473
2024
Q2 		$246K Buy
+5,924
New +$265K 0.01% 463
2024
Q1 		– Sell
-6,242
Closed -$320K – 532
2023
Q4 		$320K Buy
+6,242
New +$328K 0.01% 377
2023
Q1 		– Sell
-7,507
Closed -$540K – 266
2022
Q4 		$540K Buy
+7,507
New +$566K 0.08% 160

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Marex Group's BMY Position: Q2 2026 in Review

Marex Group sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 5,477 shares — an estimated $332K sold.

Marex Group first reported a position in BMY in Q4 2022 and held it in 9 quarters. The position peaked at $8.14M in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Marex Group reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • Marex Group sold 5,477 Bristol-Myers Squibb shares in Q2 2026, an estimated $332K.
  • Marex Group first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 9 quarters.
  • Marex Group's Bristol-Myers Squibb position peaked at $8.14M in Q1 2025.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.